Public Profile

PT. Pfizer Indonesia

PT. Pfizer Indonesia, a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in Indonesia and operates extensively across the archipelago. Established in 1952, the company has made significant strides in the pharmaceutical industry, focusing on innovative healthcare solutions that enhance the quality of life for patients. Specialising in the development and distribution of prescription medicines, vaccines, and consumer healthcare products, PT. Pfizer Indonesia is renowned for its commitment to research and development. Its core offerings include treatments for infectious diseases, oncology, and immunology, distinguished by their efficacy and safety profiles. With a strong market presence, PT. Pfizer Indonesia has achieved notable milestones, including partnerships with local healthcare providers to improve access to essential medicines. The company continues to play a pivotal role in advancing public health initiatives throughout the region.

DitchCarbon Score

How does PT. Pfizer Indonesia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

PT. Pfizer Indonesia's score of 41 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

PT. Pfizer Indonesia's reported carbon emissions

PT. Pfizer Indonesia currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This often includes setting science-based targets for emissions reductions and committing to net-zero goals. However, without specific information from PT. Pfizer Indonesia, it is not possible to detail their particular commitments or achievements in this area.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. PT. Pfizer Indonesia's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for PT. Pfizer Indonesia is in ID, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

PT. Pfizer Indonesia is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers